microRNA-mediated regulation of microRNA machinery controls cell fate decisions
Preprint
Abstract
MicroRNAs associate with Argonaute proteins, forming the microRNA-induced silencing complex (miRISC), to repress target gene expression post-transcriptionally. Although microRNAs are critical regulators in mammalian cell differentiation, our understanding of how microRNA machinery, such as the miRISC, are regulated during development is still limited. We previously showed that repressing the production of one Argonaute protein, Ago2, by Trim71 is important for mouse embryonic stem cells (mESC) self-renewal (Liu et al., 2021). Here we show that among the four Argonaute proteins in mammals, Ago2 is the major developmentally regulated Argonaute protein in mESCs. Moreover, in pluripotency, besides the Trim71-mediated regulation of Ago2 (Liu et al ., 2021), microRNA-182/microRNA-183 also repress Ago2 . Specific inhibition of this microRNA-mediated repression results in stemness defects and accelerated differentiation through the let-7 microRNA pathway. These results reveal a microRNA-mediated regulatory circuit on microRNA machinery that is critical to maintaining pluripotency.Keywords
All Related Versions
- Published version: eLife, 10.
This publication has 23 references indexed in Scilit:
- Metazoan MicroRNAsCell, 2018
- Predicting effective microRNA target sites in mammalian mRNAseLife, 2015
- The microRNA-183 cluster: the family that plays together stays togetherNucleic Acids Research, 2015
- Aberrant Regulation and Function of MicroRNAs in CancerCurrent Biology, 2014
- Regulation of microRNA biogenesisNature Reviews Molecular Cell Biology, 2014
- Diversifying microRNA sequence and functionNature Reviews Molecular Cell Biology, 2013
- Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3Cell, 2013
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- let-7 microRNAs in development, stem cells and cancerTrends in Molecular Medicine, 2008